Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004802:Eosinophilia / Q000188:drug therapy; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy; D001743:Urinary Bladder / Q000187:drug effects; D001745:Urinary Bladder Diseases / Q000139:chemically induced*
D003520:Cyclophosphamide